Skip to main content
Neurology logoLink to Neurology
. 2023 Sep 26;101(13):585–587. doi: 10.1212/WNL.0000000000207439

Frontotemporal Hypometabolism in Medication-Induced Tardive Dyskinesia

Tina Liu 1, Eduardo Benarroch 1, William Hogan 1, Andrew McKeon 1, Val J Lowe 1, Rodolfo Savica 1,
PMCID: PMC10558173  PMID: 37202164

A 59-year-old man had severe and constant oral, facial, lingual dyskinesias and memory loss after metoclopramide and prochlorperazine treatment for approximately 3 months. Brain MRI and reversible causes of memory loss (vitamin B12, folate, and thyroid-stimulating hormone) were normal. PET CT scan (Figure 1) showed significant hypometabolism of bilateral frontal, temporal lobes and caudate nuclei. Repeat PET-CT scan 3 months after discontinuing antiemetics and during treatment with 12.5 mg of tetrabenazine twice daily (Figure 2) showed marked improvement of frontotemporal and caudate hypometabolism. The patient also experienced resolution of dyskinesias and memory loss.

Figure 1. Initial PET-CT Scan.

Figure 1

Hypometabolism, bilateral frontal, temporal lobes, and caudate. Top: Patient's scan; bottom: Z-score map standard deviation below age-normative data (blue: −1 SD; light blue: −2 SD; light green: −3 SD; yellow: −4 SD; orange: −5 SD; light red: −6 SD; red: −7 SD).

Figure 2. PET CT 3 Months Post-Tetrabenazine Treatment.

Figure 2

Significant improvement of frontal, temporal lobes and caudate hypometabolism.

Medication-induced tardive dyskinesia can show a hypometabolic pattern mimicking frontotemporal dementia1 because of the frontal connection between caudate nuclei and frontal cortex.2 However, hypometabolism can improve after diagnosis and treatment. Thus, the caudate should always be evaluated during PET scan interpretation. Our case supports that PET scan results with caudate involvement and exposure to potential offending drugs can be confused with a neurodegenerative condition.

Author Contributions

T. Liu: drafting/revision of the article for content, including medical writing for content; major role in the acquisition of data. E. Benarroch: drafting/revision of the article for content, including medical writing for content; analysis or interpretation of data. W. Hogan: study concept or design; analysis or interpretation of data. A. McKeon: study concept or design; analysis or interpretation of data. V.J. Lowe: study concept or design; analysis or interpretation of data. R. Savica: drafting/revision of the article for content, including medical writing for content; major role in the acquisition of data; study concept or design; and analysis or interpretation of data.

Study Funding

No targeted funding reported.

Disclosure

The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.

References

  • 1.Foster NL, Heidebrink JL, Clark CM, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain. 2007;130(pt 10):2616-2635. [DOI] [PubMed] [Google Scholar]
  • 2.Graff-Radford J, Williams L, Jones DT, Benarroch EE. Caudate nucleus as a component of networks controlling behavior. Neurology. 2017;89(21):2192-2197. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology are provided here courtesy of American Academy of Neurology

RESOURCES